Andrew Obenshain - Feb 1, 2022 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
President and CEO, Director
Signature
/s/ Helen C. Fu, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
4
Date filed
2/3/2022, 05:08 PM
Previous filing
Jan 12, 2022
Next filing
Aug 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLUE Common Stock Award $0 +18K +7.17% $0.00 269K Feb 1, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Option (right to buy) Award $0 +90K $0.00 90K Feb 1, 2022 Common Stock 90K $7.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit awards vest over a four-year period at the rate of 25% on 01/04/2023, 25% on 01/04/2024, 25% on 01/04/2025, and 25% on 01/04/2026.
F2 Reflects a correction to the balance of securities beneficially owned to increase the balance by 4,240 shares, with respect to shares incorrectly reported as sold to satisfy tax withholding obligations of the reporting person in connection with the vesting of Restricted Stock Units.
F3 This stock option vests over a four-year period at the rate of 25% on 01/04/2023 and then in 36 equal monthly installments thereafter.